Novo Nordisk (NVO) faces a class action suit over claims it ran a pay-for-delay deal with Teva (TEVA) to delay generics for its diabetes drug Victoza. Read more here.
Novo Nordisk faces a class action lawsuit for allegedly monopolizing its diabetes drug Victoza through patent misuse and ...
Danish drugmaker Novo Nordisk faces a class action lawsuit in New York. The company is accused of using its patents to keep a ...
Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...
Danish pharmaceutical giant Novo Nordisk was hit with a class action lawsuit in New York federal court on Friday for allegedly misusing its patents to maintain a monopoly on its diabetes drug Victoza.
New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the disease.
People who slimmed down on GLP-1s found their weight creeping back up. In fact, people would regain 21.8 pounds within a year ...
Professors Svetlana Mojsov and Carlos Kenig, among other eminent figures, were selected to win the 48th session of the prize.
Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved the oral version of Wegovy® on December 22, 2025. The oral tablet, also known ...
Chances are you've heard that the GLP-1s called semaglutide (Ozempic and Wegovy) and liraglutide (Victoza and Saxenda), used for weight management and/or control of Type 2 diabetes, are also good for ...
Generic Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with Type 2 diabetes mellitus. Lupin is releasing ...
Insurance coverage for GLP-1 agonists when used for weight loss varies widely, explains GoodRX, a platform for medication savings. But these medications are often covered when prescribed for their ...